• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项多中心研究:分析白蛋白作为HHV-8/HIV阴性Castleman病的预后因素

Analysis of albumin as a prognostic factor in HHV-8/HIV-negative Castleman disease from a multicenter study.

作者信息

Yu Tiantian, Cai Qing-Qing, Zhai Qiong-Li, Li Ling, Fang Xiaosheng, Li Jianyong, Sun Ruifang, Yang Hanjin, Wang Zhaoming, Qian Wenbian, Xu-Monette Zijun Y, Young Ken H, Yu Li

机构信息

Department of Hematology and Oncology, The Second Affiliated Hospital of NanChang University, Nanchang, China.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

出版信息

Leuk Lymphoma. 2022 Dec;63(13):3082-3091. doi: 10.1080/10428194.2022.2118528. Epub 2022 Sep 7.

DOI:10.1080/10428194.2022.2118528
PMID:36074798
Abstract

As a rare lymphoproliferative disorder, many patients with HHV-8/HIV-negative Castleman disease (CD) have hypoalbuminemia. However, data is limited on whether hypoalbuminemia is an independent predictor of CD. We retrospectively collected data from 230 patients diagnosed at 12 medical centers in China and the U.S. Different classifications included 147 patients with unicentric CD (UCD) and 83 with idiopathic multicentric CD (iMCD). Adjusted smooth curve fitting showed that the relationship between albumin and all-cause death of patients with CD and iMCD was linear. Cox proportional hazards regression modeling showed a negative association between the risk of death and albumin level (hazard ratio [HR]: 0.84; 95% CI, 0.76, 0.93). Using the Kaplan-Meier method, we determined that hypoproteinemia was a risk factor for poorer prognosis in patients with CD, UCD, and iMCD. Albumin was independently and negatively associated with the risk of death in CD patients, especially those with iMCD.

摘要

作为一种罕见的淋巴增生性疾病,许多HHV-8/ HIV阴性的Castleman病(CD)患者存在低白蛋白血症。然而,关于低白蛋白血症是否为CD的独立预测因素的数据有限。我们回顾性收集了来自中国和美国12个医学中心诊断的230例患者的数据。不同分类包括147例单中心CD(UCD)患者和83例特发性多中心CD(iMCD)患者。调整后的平滑曲线拟合显示,白蛋白与CD和iMCD患者全因死亡之间的关系呈线性。Cox比例风险回归模型显示死亡风险与白蛋白水平呈负相关(风险比[HR]:0.84;95%置信区间,0.76,0.93)。使用Kaplan-Meier方法,我们确定低蛋白血症是CD、UCD和iMCD患者预后较差的危险因素。白蛋白与CD患者尤其是iMCD患者的死亡风险独立且呈负相关。

相似文献

1
Analysis of albumin as a prognostic factor in HHV-8/HIV-negative Castleman disease from a multicenter study.一项多中心研究:分析白蛋白作为HHV-8/HIV阴性Castleman病的预后因素
Leuk Lymphoma. 2022 Dec;63(13):3082-3091. doi: 10.1080/10428194.2022.2118528. Epub 2022 Sep 7.
2
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.病毒组捕获测序不能在局灶性和特发性多中心 Castleman 病中识别出活跃的病毒感染。
PLoS One. 2019 Jun 26;14(6):e0218660. doi: 10.1371/journal.pone.0218660. eCollection 2019.
3
Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.HIV和HHV-8阴性的Castleman病的临床和病理特征
Blood. 2017 Mar 23;129(12):1658-1668. doi: 10.1182/blood-2016-11-748855. Epub 2017 Jan 18.
4
[Multicentric Castlemans disease. Symptoms, diagnostics and therapy].[多中心性Castleman病。症状、诊断与治疗]
Vnitr Lek. 2022 Winter;68(1):41-53.
5
From Castleman disease histopathological features to idiopathic multicentric Castleman disease: a multiparametric approach to exclude potential iMCD histopathological mimickers.从 Castleman 病的组织病理学特征到特发性多中心 Castleman 病:一种排除潜在 iMCD 组织病理学模拟物的多参数方法。
J Clin Pathol. 2024 Apr 18;77(5):318-323. doi: 10.1136/jcp-2022-208696.
6
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.一项在中国开展的采用Castleman病协作网(CDCN)标准的Castleman病全国多中心回顾性研究。
Lancet Reg Health West Pac. 2023 Mar 24;34:100720. doi: 10.1016/j.lanwpc.2023.100720. eCollection 2023 May.
7
Clinical characteristics and outcomes of Castleman disease: a multicenter Consortium study of 428 patients with 15-year follow-up.Castleman病的临床特征与预后:一项对428例患者进行15年随访的多中心联合研究
Am J Cancer Res. 2022 Sep 15;12(9):4227-4240. eCollection 2022.
8
Clinical and pathological characteristics of Castleman disease: an observational study in a Spanish tertiary hospital.卡斯尔曼病的临床和病理特征:一家西班牙三级医院的观察性研究。
Leuk Lymphoma. 2019 Dec;60(14):3442-3448. doi: 10.1080/10428194.2019.1639168. Epub 2019 Jul 15.
9
Comprehensive analysis of 65 patients with Castleman disease in a single center in China.中国单中心 65 例血管滤泡性淋巴结增生症患者的综合分析。
Sci Rep. 2022 May 24;12(1):8694. doi: 10.1038/s41598-022-12797-y.
10
The full spectrum of Castleman disease: 273 patients studied over 20 years.卡斯特曼病全谱:20年间研究的273例患者
Br J Haematol. 2018 Jan;180(2):206-216. doi: 10.1111/bjh.15019. Epub 2017 Nov 16.

引用本文的文献

1
Complete excision and management of large hyaline-vascular pelvic Castleman's disease with coexisting cholecystolithiasis: A rare case report.伴有胆囊结石的大型透明血管型盆腔Castleman病的完整切除及治疗:1例罕见病例报告
Int J Surg Case Rep. 2025 Mar;128:111019. doi: 10.1016/j.ijscr.2025.111019. Epub 2025 Feb 7.